This company has been marked as potentially delisted and may not be actively trading. resTORbio (TORC) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock TORC vs. WHWK, PYRGF, AADI, EGRX, ATNM, NBRV, OSTX, ELYM, HILS, and NNVCShould you be buying resTORbio stock or one of its competitors? The main competitors of resTORbio include Whitehawk Therapeutics (WHWK), PyroGenesis Canada (PYRGF), Aadi Bioscience (AADI), Eagle Pharmaceuticals (EGRX), Actinium Pharmaceuticals (ATNM), Nabriva Therapeutics (NBRV), OS Therapies (OSTX), Eliem Therapeutics (ELYM), Hillstream BioPharma (HILS), and NanoViricides (NNVC). resTORbio vs. Its Competitors Whitehawk Therapeutics PyroGenesis Canada Aadi Bioscience Eagle Pharmaceuticals Actinium Pharmaceuticals Nabriva Therapeutics OS Therapies Eliem Therapeutics Hillstream BioPharma NanoViricides Whitehawk Therapeutics (NASDAQ:WHWK) and resTORbio (NASDAQ:TORC) are both small-cap pharmaceutical preparations industry companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, media sentiment, institutional ownership, profitability, valuation and earnings. Which has preferable earnings & valuation, WHWK or TORC? Whitehawk Therapeutics has higher revenue and earnings than resTORbio. resTORbio is trading at a lower price-to-earnings ratio than Whitehawk Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioWhitehawk Therapeutics$25.98M3.26-$63.69M$0.1611.25resTORbioN/AN/A-$82.74M-$2.41-0.33 Does the media refer more to WHWK or TORC? In the previous week, Whitehawk Therapeutics' average media sentiment score of 0.00 equaled resTORbio'saverage media sentiment score. Company Overall Sentiment Whitehawk Therapeutics Neutral resTORbio Neutral Is WHWK or TORC more profitable? Whitehawk Therapeutics has a net margin of 99.42% compared to resTORbio's net margin of 0.00%. Whitehawk Therapeutics' return on equity of -56.73% beat resTORbio's return on equity.Company Net Margins Return on Equity Return on Assets Whitehawk Therapeutics99.42% -56.73% -48.68% resTORbio N/A -78.12%-71.63% Which has more volatility & risk, WHWK or TORC? Whitehawk Therapeutics has a beta of 0.55, meaning that its share price is 45% less volatile than the S&P 500. Comparatively, resTORbio has a beta of 2.43, meaning that its share price is 143% more volatile than the S&P 500. Do institutionals and insiders believe in WHWK or TORC? 52.1% of Whitehawk Therapeutics shares are held by institutional investors. Comparatively, 46.2% of resTORbio shares are held by institutional investors. 49.9% of Whitehawk Therapeutics shares are held by insiders. Comparatively, 11.8% of resTORbio shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummaryWhitehawk Therapeutics beats resTORbio on 8 of the 9 factors compared between the two stocks. Get resTORbio News Delivered to You Automatically Sign up to receive the latest news and ratings for TORC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TORC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TORC vs. The Competition Export to ExcelMetricresTORbioPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$28.80M$816.22M$5.54B$9.41BDividend YieldN/A4.84%3.75%4.03%P/E Ratio-0.441.2021.0120.09Price / SalesN/A25.49433.8199.01Price / CashN/A19.5636.1658.27Price / Book0.356.878.125.65Net Income-$82.74M-$4.17M$3.25B$257.91M resTORbio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TORCresTORbioN/A$0.79+1.3%N/A-40.5%$28.80MN/A-0.44N/AWHWKWhitehawk TherapeuticsN/A$1.94-5.4%N/AN/A$96.57M$25.98M0.0040PYRGFPyroGenesis Canada0.089 of 5 stars$0.32-2.7%N/A-51.6%$60.13M$9.14M-5.3590Gap UpHigh Trading VolumeAADIAadi Bioscience0.3935 of 5 stars$2.05+7.3%$1.67-18.7%+24.2%$50.63M$25.07M-0.9040EGRXEagle Pharmaceuticals2.4921 of 5 stars$3.74+5.4%N/A-38.3%$48.57M$257.55M0.00100Gap DownATNMActinium Pharmaceuticals2.1347 of 5 stars$1.52-3.5%$4.00+164.0%N/A$47.26MN/A-1.0930Positive NewsNBRVNabriva TherapeuticsN/AN/AN/AN/A$45.46M$35.59M0.0070OSTXOS Therapies2.2498 of 5 stars$1.58+1.3%$18.00+1,039.2%N/A$44.40MN/A-1.84N/AELYMEliem TherapeuticsN/A$1.42+3.6%N/A-79.6%$42.25MN/A-2.689HILSHillstream BioPharmaN/A$1.69-2.3%N/A-61.4%$29.75MN/A-2.351NNVCNanoViricides0.3733 of 5 stars$1.46-8.8%N/A-27.4%$23.47MN/A-2.0320Positive News Related Companies and Tools Related Companies Whitehawk Therapeutics Alternatives PyroGenesis Canada Alternatives Aadi Bioscience Alternatives Eagle Pharmaceuticals Alternatives Actinium Pharmaceuticals Alternatives Nabriva Therapeutics Alternatives OS Therapies Alternatives Eliem Therapeutics Alternatives Hillstream BioPharma Alternatives NanoViricides Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TORC) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...GoldCo Precious Metals | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding resTORbio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share resTORbio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TORC Stock Alerts